Form 4 for IMNM Immunome Inc.
Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0002026600-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | 2025-12-19 | IMNM | Tsai Philip | Chief Technical Off | P - Purchase | $20.49 | +10.0K | 43.3K | +30% | +$204.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | P | A | 10,000 | $20.49 | 43,300 | D | — | — |